Alnylam Pharmaceuticals

Scientist, Advanced Cell Models & Delivery Biology

Alnylam Pharmaceuticals  •  $110k - $166k/yr  •  United States (Onsite)  •  5 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

The successful candidate will develop and apply advanced in vitro cellular models to support the discovery and optimization of novel delivery strategies for RNAi therapeutics. This individual will play a key role in evaluating ligand-mediated delivery, receptor biology, cellular uptake, and pharmacological activity across multiple therapeutic areas.

This position is onsiteand will be primarily located in Cambridge, MA.

Key Responsibilities

  • Work collaboratively with internal teams and external partners to establish, optimize, and apply advanced 2D and 3D cellular models, including primary cell systems, co-cultures, organoids, spheroids, and microphysiological systems.
  • Design and execute studies to evaluate receptor-mediated delivery, ligand activity, cellular uptake, and target engagement of RNAi therapeutics.
  • Identify gaps in existing model capabilities and develop novel cellular systems to address emerging scientific questions and program needs.
  • Utilize imaging-based technologies, protein-based assays, and molecular biology techniques to characterize receptor expression, uptake mechanisms, and biological responses.
  • Generate mechanistic insights to support ligand selection, delivery optimization, and candidate progression across therapeutic programs.
  • Collaborate closely with other teams to design and execute experiments that inform key project decisions.
  • Evaluate the predictive value and translational relevance of in vitro models and contribute to the advancement of next-generation cellular platforms.
  • Communicate scientific findings effectively through presentations, reports, and cross-functional discussions.
  • Prepare clearly articulated experimental reports and data presentations.

Qualifications

  • Ph.D. in Cell Biology, Molecular Biology, Pharmacology, Biomedical Engineering, or a related biological discipline with 0-3 years of industry and/or post-doctoral experience.
  • Strong hands-on experience with advanced in vitro cellular systems, including primary cells and complex 2D/3D culture models such as organoids, spheroids, co-cultures, tissue slices, or microphysiological systems.
  • Experience developing and applying cell-based assays to address mechanistic and translational research questions.
  • Experience in one or more of the following areas: receptor biology, cellular uptake, intracellular trafficking, ligand-receptor interactions, imaging, or protein-based characterization methods.
  • Strong experimental design, troubleshooting, and data interpretation skills.
  • Self-motivated, collaborative, and able to manage multiple priorities in a fast-paced research environment.
  • Excellent communication and presentation skills.

Preferred Qualifications

    • Experience with oligonucleotide therapeutics, RNAi, ASOs, peptides, antibodies, or targeted delivery technologies.
    • Experience with advanced imaging platforms, quantitative image analysis, or receptor-mediated delivery systems.
    • Experience with cardiac cell systems, including primary, iPSC-derived, or advanced in vitro cardiac models.

#LI-JR1

U.S. Pay Range

$110,400.00 - $165,600.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

About Alnylam

We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.

Alnylam Pharmaceuticals

About Alnylam Pharmaceuticals

SILENCE DISEASE. AMPLIFY LIFE.™

Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.

Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.

We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024).

We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.

See our social media community guidelines: https://bit.ly/2FcRhJy.

Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Fraudulent Recruitment Activity

Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

Industry
Biotech & Life Sciences
Company Size
1,001-5,000 employees
Headquarters
Cambridge, Massachusetts
Year Founded
2002
Social Media